Publication | Closed Access
HER2-positive breast cancer: 18F-FDG PET for early prediction of response to trastuzumab plus taxane-based neoadjuvant chemotherapy
80
Citations
31
References
2014
Year
Breast OncologyMedicinePathologyEarly PredictionBreast CancerCancer TreatmentOncologyRadiation Oncology18F-fdg PetEndocrine-related CancerHer2-positive Breast Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1